APRIL-deficient mice have normal immune system development

被引:147
作者
Varfolomeev, E
Kischkel, F
Martin, F
Seshasayee, D
Wang, H
Lawrence, D
Olsson, C
Tom, L
Erickson, S
French, D
Schow, P
Grewal, QS
Ashkenazi, A [1 ]
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Physiol, San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA
关键词
D O I
10.1128/MCB.24.3.997-1006.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
APRIL (a proliferation-inducing ligand) is a member of the tumor necrosis factor (TNF) superfamily. APRIL mRNA shows high levels of expression in tumors of different origin and a low level of expression in normal cells. APRIL shares two TNF receptor family members, TACI and BCMA, with another TNF homolog, BLyS/BAFF. BLyS is involved in regulation of B-cell activation and survival and also binds to a third receptor, BR3/BAFF-R, which is not shared with APRIL. Recombinant APRIL and BLyS induce accumulation of B cells in mice, while BLyS deficiency results in severe B-cell dysfunction. To investigate the physiological role of APRIL, we generated mice that are deficient in its encoding gene. APRIL(-/-) mice were viable and fertile and lacked any gross abnormality. Detailed histological analysis did not reveal any defects in major tissues and organs, including the primary and secondary immune organs. T- and B-cell development and in vitro function were normal as well, as were T-cell-dependent and -independent in vivo Immoral responses to antigenic challenge. These data indicate that APRIL is dispensable in the mouse for proper development. Thus, BLyS may be capable of fulfilling APRIL's main functions.
引用
收藏
页码:997 / 1006
页数:10
相关论文
共 54 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   Blood dendritic cells interact with splenic marginal zone B cells to initiate T-Independent immune responses [J].
Balázs, M ;
Martin, F ;
Zhou, T ;
Kearney, JF .
IMMUNITY, 2002, 17 (03) :341-352
[3]  
Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
[4]  
2-S
[5]   TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis [J].
Chicheportiche, Y ;
Bourdon, PR ;
Xu, HD ;
Hsu, YM ;
Scott, H ;
Hession, C ;
Garcia, I ;
Browning, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32401-32410
[6]  
Gerber HP, 1999, DEVELOPMENT, V126, P1149
[7]   Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome [J].
Groom, J ;
Kalled, SL ;
Cutler, AH ;
Olson, C ;
Woodcock, SA ;
Schneider, P ;
Tschopp, J ;
Cachero, TG ;
Batten, M ;
Wheway, J ;
Mauri, D ;
Cavill, D ;
Gordon, TP ;
Mackay, CR ;
Mackay, F .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (01) :59-68
[8]   TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease [J].
Gross, JA ;
Johnston, J ;
Mudri, S ;
Enselman, R ;
Dillon, SR ;
Madden, K ;
Xu, WF ;
Parrish-Novak, J ;
Foster, D ;
Lofton-Day, C ;
Moore, M ;
Littau, A ;
Grossman, A ;
Haugen, H ;
Foley, K ;
Blumberg, H ;
Harrison, K ;
Kindsvogel, W ;
Clegg, CH .
NATURE, 2000, 404 (6781) :995-999
[9]   TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS [J].
Gross, JA ;
Dillon, SR ;
Mudri, S ;
Johnston, J ;
Littau, A ;
Roque, R ;
Rixon, M ;
Schou, O ;
Foley, KP ;
Haugen, H ;
McMillen, S ;
Waggie, K ;
Schreckhise, RW ;
Shoemaker, K ;
Vu, T ;
Moore, M ;
Grossman, A ;
Clegg, CH .
IMMUNITY, 2001, 15 (02) :289-302
[10]   APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth [J].
Hahne, M ;
Kataoka, T ;
Schröter, M ;
Hofmann, K ;
Irmler, M ;
Bodmer, JL ;
Schneider, P ;
Bornard, T ;
Holler, N ;
French, LE ;
Sordat, B ;
Rimoldi, D ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) :1185-1190